Myasthenia Gravis Foundation of America

The foundation a mother started in 1952 when her teenage daughter was diagnosed with a rare disease that had little information behind it, now gathering patients, neurologists, researchers and companies around a single vision: A World Without MG.

18named by MGFA
70named by peers

Financial profile

Myasthenia Gravis Foundation Of America Inc · EIN 13-5672224 · 501(c)(3)

Fiscal yearTotal revenueContributionsProgram servicesTotal expensesNet assetsYear end
FY2025$7,559,812$6,346,619$585,239$7,077,785$13,081,885Dec 2025
FY2024$5,670,792$4,824,285$178,132$5,078,413$11,704,240Dec 2024
FY2023$3,555,325$3,033,495$112,906$3,580,103$10,611,110Dec 2023
FY2022$4,388,529$3,608,887$452,123$3,790,735$10,032,823Dec 2022
FY2021$3,840,681$2,800,892$189,501$3,008,153$10,858,739Dec 2021
FY2020$3,577,214$3,228,993$30,078$2,477,510$9,734,054Dec 2020

Figures exactly as reported. A blank cell was blank on the form. The fiscal year links to the filing.

Something wrong here? Tell us what we missed.

Peer societies

Five societies MGFA is read alongside.

Who backs MGFA

Every company MGFA names publicly as a supporter, exactly as published. Companies also named by other associations on Sociogene come first.

CompanySupport as publishedAlso named by
AlexionPublished as Alexion (logo)Meeting sponsorAAN AASLD AACCN AANEM ACC +3
AmgenPublished as Amgen (logo)Meeting sponsorAcademyHealth AAAAI AAFP AAN AAO +3
argenxPublished as argenx (logo)Meeting sponsorAAN AANEM ACR ANA ASA +3
EMD SeronoPublished as EMD Serono (logo)Meeting sponsorAANEM ACR AOSSM ASRO ASRM +3
Johnson & JohnsonPublished as Johnson & Johnson (logo)Meeting sponsorAMCP AcademyHealth ACS AEE AAD +3
NovartisPublished as Novartis (logo)Meeting sponsorADLM AAD AAN AACR AANEM +3
RegeneronPublished as Regeneron (logo)Meeting sponsorAAAAI AAD AAP AACR AASLD +3
UCBPublished as UCB (logo)Meeting sponsorAAD AAN AANEM AANN ACNS +3
Vertex PharmaceuticalsPublished as Vertex (logo)Meeting sponsorACS AAEM AAPMR AAPA AANA +3
Catalyst PharmaceuticalsPublished as Catalyst LogoMeeting sponsorAAPMR AANEM ASBMR BIO COA +2
Evernorth Health ServicesPublished as Evernorth Health Services (logo)Meeting sponsorA1F IFEBP PHA SIIA
ImmunovantPublished as Immunovant (logo)Symposium SponsorAAN AACE ATA
Merck KGaAPublished as MERCK (logo), merckgroup.comMeeting sponsorASRO IASLC IUPAC
ArcellxPublished as Arcellx (logo)Meeting sponsorASTCT
Cartesian TherapeuticsPublished as Cartesian (logo)Meeting sponsorASTCT
Vor BioPublished as VOR (logo)Meeting sponsorSjögren's Foundation
InfuCareRxPublished as InfuCareRx (logo)Meeting sponsorOnly MGFA, so far
NMD PharmaPublished as NMD Pharma (logo)Meeting sponsorOnly MGFA, so far
Sources: 4 published lists, read October 2026

15th International Conference on Myasthenia Gravis and Related Disorders sponsors. Read October 6, 2026. Sponsors of the 15th International Conference on Myasthenia Gravis and Related Disorders, 2025.

Thank You to Our 2026 Conference Partners. Read October 6, 2026. Partners of the 2026 MGFA National Patient Conference.

Thank You to Our 2026 MG Walk Sponsors. Read October 6, 2026. Sponsors of the 2026 MG Walks.

Thank You to Our 2026 Scientific Session Strategic Partners. Read October 6, 2026. Strategic partners of the 2026 MGFA Scientific Session.

Something wrong here? Tell us what we missed.

Who backs MGFA's peers, but not MGFA

Companies named publicly by at least one of MGFA's five peer societies, and not found in MGFA's reviewed public records.

CompanyFSARALRAHAA1FPeers
BiogenCore Program SponsorCorporate Leadership Circle2 of 4
Advanced AeromedicalNamed1 of 4
Advanced Infusion CareGold Sponsors1 of 4
AesculapSilver1 of 4
AIRNAEmerging Therapies in Alpha 1 Sponsors1 of 4
Alexion PharmaceuticalsNamed1 of 4
Amalie Oil CompanyNamed1 of 4
Anuncia MedicalPublished as Anuncia - SILVERSilver1 of 4
Arrowhead PharmaceuticalsNamed1 of 4
AstraZenecaCorporate Leadership Circle1 of 4
AuriniaCorporate Leadership Circle1 of 4
AvevoRXGold Sponsors1 of 4
Beam TherapeuticsEmerging Therapies in Alpha 1 Sponsors1 of 4
Big Timber Cattle CompanyNamed1 of 4
Biohaven PharmaceuticalsNamed1 of 4
Biologics by McKessonNamed1 of 4
Bristol Myers SquibbCorporate Leadership Circle1 of 4
Brown & BrownNamed1 of 4
Cabaletta BioCorporate Leadership Circle1 of 4
CereVascPublished as CeraVascSilver1 of 4
Cerulean ScientificPublished as Cerulean - CopperCopper1 of 4
Clarus MedicalBronze1 of 4
Codman Specialty SurgicalPublished as Codman Specialty Surgical, an Integra LifeSciences CompanyGold1 of 4
Columbia Food ServicePublished as Columbia Food Service Co., Inc.Named1 of 4
CSI PharmacyGold Sponsors1 of 4
CSLPlatinum Sponsors1 of 4
Design TherapeuticsNamed1 of 4
Duncan Real EstateNamed1 of 4
El Dorado HoldingsNamed1 of 4
Foley, Baron, Metzger & JuipNamed1 of 4
GenentechNamed1 of 4
GrifolsPlatinum Sponsors1 of 4
GSKCorporate Leadership Circle1 of 4
Horizon PharmaCorporate Leadership Circle1 of 4
Huffman & Huffman Brothers-In-LawNamed1 of 4
HyperfineNamed1 of 4
JanssenCorporate Leadership Circle1 of 4
Kitea HealthCopper1 of 4
Larimar TherapeuticsCore Program Sponsor1 of 4
Leon MaxNamed1 of 4
Lexeo TherapeuticsNamed1 of 4
LillyCorporate Leadership Circle1 of 4
Locust CiderNamed1 of 4
Longeviti Neuro SolutionsCopper1 of 4
Lupus News TodayNamed1 of 4
MadSciPublished as MadSci - COPPERCopper1 of 4
MedtronicSilver1 of 4
MJH Life SciencesPublished as MJHNamed1 of 4
Neurocrine BiosciencesNamed1 of 4
Notis Professional ServicesNamed1 of 4
PfizerCorporate Leadership Circle1 of 4
Prime MedicineEmerging Therapies in Alpha 1 Sponsors1 of 4
PTC TherapeuticsNamed1 of 4
Raymond James FinancialNamed1 of 4
RhaeosPublished as Rhaeos - CopperCopper1 of 4
RheumLiveNamed1 of 4
SanofiPlatinum Sponsors1 of 4
ServierNamed1 of 4
Shumaker, Loop & KendrickNamed1 of 4
Solid BiosciencesNamed1 of 4
Southern Pine Timber ProductsNamed1 of 4
Stealth BioTherapeuticsNamed1 of 4
Stellar RealtyNamed1 of 4
TakedaPlatinum Sponsors1 of 4
Tessera TherapeuticsEmerging Therapies in Alpha 1 Sponsors1 of 4
Vanguard Protex GlobalNamed1 of 4
Voyager TherapeuticsNamed1 of 4
Wave Life SciencesEmerging Therapies in Alpha 1 Sponsors1 of 4
WCBSNamed1 of 4
Wilspec TechnologiesNamed1 of 4

Something wrong here? Tell us what we missed.

The outside view

The foundation a mother started in 1952 when her teenage daughter was diagnosed with a rare disease that had little information behind it, now gathering patients, neurologists, researchers and companies around a single vision: A World Without MG.

  • Consensus
  • Build
  • Outward
  • Operational

Their shape

The Movement

Gathered around a cause, and built to move.

The Movement is mission-led and built to mobilize, organized around changing something in the world. Its gift is passion and external impact, its challenge is turning momentum into something that lasts.

Also reads toward The Village and The Legacy.

Strengths

→Real influence on the wider field.
→Members are motivated by a clear why.
→Quick to rally around what matters now.

Not an official page of Myasthenia Gravis Foundation of America. Sociogene does not consult. Everything here comes from public sources, dated and linked. Something wrong here? Tell us what we missed.